Publikationen 2020

  • Schlömer H, Kalke J (2020) Ist das Cannabisverbot hilfreich für die suchtpräventive Arbeit? Public Health Forum; 28: 273-276
  • Kahl J, Holl J, Grundmann J, Lotzin A, Hiller P, Schroeder K, Schulte B, Barnow S, Schäfer I (2020)  Difficulties in emotion regulation as an underlying mechanism for the development and maintenance of PTSD in female patients with substance use disorders. Substance Use & Misuse, 55:13, 2184-2193, DOI: 10.1080/10826084.2020.1797805
  • Schulte B, Lehmann K, Schmidt CS, Rühling E, Weber B, Schäfer I, Reimer J, Verthein U (2020) Addiction recovery among opioid-dependent patients treated with injectable subcutaneous depot buprenorphine: Study protocol of a non-randomized prospective observational study (ARIDE). Frontiers in Psychiatry. doi.org/10.3389/fpsyt.2020.580863
  • Zimmermann R, Külper-Schiek W, Steffen G, Gillesberg Lassen S, Bremer V, Dudareva S & die Hepatitis-Monitoring-Arbeitsgruppe (2020) Wie lässt sich die Eliminierung von Hepatitis B, C und D in Deutschland messen? Ergebnisse eines interdisziplinären Arbeitstreffens. Bundesgesundheitsblatt, https://doi.org/10.1007/s00103-020-03260-2
  • Frischknecht U, Hoffmann S, Steinhauser A, Lindemann L, Buchholz A, Manthey J, Schulte B, Rehm J, Kraus L, Verthein U, Reimer J, Kiefer F (2020) Diagnostik und Behandlung alkoholbezogener Störungen – Versorgerbefragung zur Erarbeitung von Strategien der Leitlinienimplementierung. Suchttherapie, DOI 10.1055/a-1265-4687
  • Manthey J, Kilian C, Schomerus G, Kraus L, Rehm J, Schulte B (2020) Veränderungen im Alkoholkonsum in Deutschland und Europa während des (bisherigen) Höhepunkts der SARS-CoV-2 Pandemie. SUCHT, 66, 1–12
  • Grundmann J, Lotzin A, Sehner S, Verthein U, Hiller P, Hiersemann R, Lincoln TM, Hillemacher T, Schneider B, Driessen M, Scherbaum N, Dotten AC, Schäfer I (2020) Predictors of attendance in outpatient group treatment for women with posttraumatic stress disorder and substance use disorder. Psychother Res. 15:1-12. doi: 10.1080/10503307.2020.1817604
  • Meyer G, Kalke J & Hayer T (2020) Auswirkungen einer Reduktion der Verfügbarkeit von Glücksspielen auf die Prävalenz der Spielteilnahme und glücksspielbezogener Störungen: Ein systematischer Review. Beiträge zum Glücksspielwesen; 3: 10-19
  • Lotzin A, Acquarini E, Ajdukovic D, Ardino V, Bo?ttche M, Bondjers K, Bragesjo? M, Dragan M,  Grajewski P, Figueiredo-Braga M, Gelezelyte O, Darejan Javakhishvili J, Kazlauskas E, Knefel M, Lueger-Schuster B, Makhashvili N, Mooren T, Sales L, Stevanovic A, Scha?fer I (2020) Stressors, coping and symptoms of adjustment disorder in the course of the COVID-19 pandemic – study protocol of the European Society for Traumatic Stress Studies (ESTSS) pan-European study, European Journal of Psychotraumatology, 11:1, 1780832, DOI: 10.1080/20008198.2020.1780832
  • Manthey J, Kalke J, Rehm J, Rosenkranz M, Verthein U (2020) Controlled administration of cannabis to mitigate cannabis-attributable harm among recreational users: a quasi-experimental study in Germany. F1000Res; 9: 201. doi: 10.12688/f1000research.22612.1
  • Schulte B, Schmidt CS, Manthey J, Strada L, Christensen S, Cimander K, Görne H, Khaykin P, Scherbaum N, Walcher S, Mauss S, Schäfer I, Verthein U, Rehm J,  Reimer J (2020) Clinical and Patient-Reported Outcomes of Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C Among Patients on Opioid Agonist Treatment: A Real-world Prospective Cohort Study. Open Forum Infectious Diseases, https://doi.org/10.1093/ofid/ofaa317
  • Baschirotto C, Lehmann K, Kuhn S, Reimer J & Verthein U (2020) Switching opioid-dependent patients in substitution treatment from racemic methadone, levomethadone and buprenorphine to slow-release oral morphine: Analysis of the switching process in routine care. Journal of Pharmacological Sciences, 144: 9-15.
  • Rehm J, Kilian C, Rovira P, Shield KD, Manthey J (2020) The elusiveness of representativeness in general population surveys for alcohol Drug Alcohol Rev. doi:10.1111/dar.13148
  • Jané-Llopis E, Anderson P, Piazza M, O'Donnell A, Gual A, Schulte B, Pérez Gómez A, de Vries H,  Natera Rey G, Kokole D, Bustamante I, Braddick F, Mejía Trujillo J, Solovei A, Pérez De León A, Kaner E, Matrai S, Manthey J, Mercken L, López-Pelayo H, Rowlands G, Schmidt C, Rehm J (2020) Implementing primary healthcare-based measurement, advice and treatment for heavy drinking and comorbid depression at the municipal level in three Latin American countries: final protocol for a quasiexperimental study (SCALA study). BMJ Open, http://dx.doi.org/10.1136/bmjopen-2020-038226
  • Rehm J, Manthey J (2020) Cannabis and public health: a global experiment without control. World Psychiatry. 19:192-194. doi:10.1002/wps.20740
  • Verthein U, Buth S, Daubmann A, Martens MS, Schulte B (2020) Trends in risky prescriptions of opioid analgesics from 2011 to 2015 in Northern Germany. Journal of Psychopharmacology; 34(11) 1210–17. doi: 10.1177/0269881120936544
  • Javakhishvili JD, Ardino V, Bragesjö M, Kazlauskas E, Olff M, Schäfer I (2020) Trauma-informed responses in addressing public mental health consequences of the COVID-19 pandemic: position paper of the European Society for Traumatic Stress Studies (ESTSS). Eur J Psychotraumatol. 2020;11(1):1780782. doi:10.1080/20008198.2020.1780782
  • Llamosas-Falcón L, Shield KD, Gelovany M, Manthey J, Rehm J (2020) Alcohol use disorders and the risk of progression of liver disease in people with hepatitis C virus infection - a systematic review. Subst Abuse Treat Prev Policy. 2020 Jun 30;15(1):45. doi: 10.1186/s13011-020-00287-1
  • Rehm J, Kilian C, Ferreira-Borges C, Jernigan D, Monteiro M, Parry CDH, Sanchez ZM, Manthey J (2020) Alcohol use in times of the COVID 19: Implications for monitoring and policy. Drug Alcohol Rev. 2020 May;39(4):301-304. doi: 10.1111/dar.13074
  • Schulte B, Schmidt CS, Strada L, Rosenkranz M, Schäfer I, Verthein U, Reimer
    J (2020) Hepatitis C Virus Prevalence and Incidence in a Large Nationwide Sample of Patients in Opioid Substitution Treatment in Germany: A Prospective Cohort Study. Clin Infect Dis 6;70:2199-2205. doi: 10.1093/cid/ciz661
  • Muehlhan M, Höcker A, Miller R, Trautmann S, Wiedemann K, Lotzin A, Barnow S, Schäfer I (2020). HPA axis stress reactivity and hair cortisol concentrations in healthy controls and recently detoxified alcoholics with and without childhood maltreatment. Addiction Biology, 25(1):e12681
  • O’Donnell A, Hanratty B, Schulte B, Kaner E (2020) Patients’ experiences of alcohol screening and advice in primary care: a qualitative study. BMC Fam Pract 21, 68. https://doi.org/10.1186/s12875-020-01142-9
  • Knefel M, Kantor V, Nicholson AA, Schiess-Jokanovic J, Weindl D, Schäfer I, Lueger-Schuster B (2020) A brief transdiagnostic psychological intervention for Afghan asylum seekers and refugees in Austria: a randomized controlled trial. Trials; 21: 57. doi: 10.1186/s13063-019-3839-9
  • Sornpaisarn B, Shield K, Manthey J, Limmade Y, Low WY, Van Thang V, Rehm J (2020) Alcohol consumption and attributable harm in middle-income South-East Asian countries: Epidemiology and policy options. Int J Drug Policy. 2020 Jul 22;83:102856. doi: 10.1016/j.drugpo.2020.102856
  • Probst C, Manthey J, Neufeld M, et al. (2020) Meeting the Global NCD Target of at Least 10% Relative Reduction in the Harmful Use of Alcohol: Is the WHO European Region on Track?. Int J Environ Res Public Health. 17:3423. doi:10.3390/ijerph17103423
  • Manthey J, Carr S, Rehm J (2020) Definition of a 'standard joint equivalent': Comment on "Who consumes most of the cannabis in Canada? Profiles of cannabis consumption by quantity". Drug Alcohol Depend, 1;206:107731. doi: 10.1016/j.drugalcdep.2019.107731
  • Gaebel W, Stricker J, Riesbeck M, Zielasek J, Kerst A, Meisenzahl-Lechner E, Köllner V, Rose M, Hofmann T, Schäfer I, Lotzin A, Briken P, Klein V, Brunner F, Keeley JW, Rebello TJ, Andrews HF, Reed GM, Vogel U, Hasan A, Falkai P (2020) Accuracy of Diagnostic Classification and Clinical Utility Assessment of ICD-11 Compared to ICD-10 in 10 Mental Disorders: Findings From a Web-Based Field Study. European Archives of Psychiatry and Clinical Neuroscience, 270(3): 281-289
  • Kilian C, Manthey J, Probst C, et al. (2020) Why Is Per Capita Consumption Underestimated in Alcohol Surveys? Results from 39 Surveys in 23 European Countries. Alcohol Alcohol. 55:554-563. doi:10.1093/alcalc/agaa048
  • Manthey J, Probst C, Kilian C, Moskalewicz J, Sieros?awski J, Karlsson T, Rehm J (2020) Unrecorded Alcohol Consumption in Seven European Union Countries. Eur Addict Res. doi: 10.1159/000506333
  • Buchholz A, Dams J, Rosahl A, Hempleman J, König HH, Konnopka A, Kraus L, Kriston L, Piontek D, Reimer J, Röhrig J, Scherbaum N, Silkens A, Berner M (2020) Patient-Centered Placement Matching of Alcohol-Dependent Patients Based on a Standardized Intake Assessment: Primary Outcomes of an Exploratory Randomized Controlled Trial. Eur Addict Res;26(3):109-121. doi:10.1159/000505913
  • Reimer J, Vogelmann T, Trümper D, Scherbaum N (2020) Impact of Buprenorphine Dosage on the Occurrence of Relapses in Patients with Opioid Dependence. Eur Addict Res; 26 :77-84 doi:10.1159/000505294
  • Llamosas-Falcón L, Manthey J, Rehm J (2020) Changes in alcohol consumption in Spain between 1990 and 2019. Adicciones. 0:1400. doi:10.20882/adicciones.1400
  • Rehm J, Crépault JF, Wettlaufer A, Manthey J, Shield K (2020) What is the best indicator of the harmful use of alcohol? A narrative review. Drug Alcohol Rev. doi: 10.1111/dar.13053
  • Reiß M, Schulte B, Schmidt CS, Carstens A, Görne H, Kreibich R, Tietje W, Weber B, Schnell T, Verthein U (2020) Selbst- und Fremdbeurteilung von Depressivität bei opioidabhängigen Patienten in Substitutionsbehandlung. Suchttherapie, 21: 25-31. DOI: 10.1055/a-1032-6735
  • Martens MS, Zurhold H, Rosenkranz M,  O’Donnell A, Addison M, Spencer L, McGovern W, Gabrhelík R, Petruželka B, Rowicka M, Liebregts N, Degkwitz P, Kaner E, Verthein (2020) Using life course charts to assess and compare trajectories of amphetamine type stimulant consumption in different user groups: a cross-sectional study. Harm Reduct J 17; 8 doi:10.1186/s12954-019-0339-x
  • Schulte B, O’Donnell A, Lahusen H, Lindemann C, Prilutskaya M, Yussopov O, Kaliyeva Z, Martens MS, Verthein U (2020) Feasibility of alcohol screening and brief intervention in primary health care in Kazakhstan: study protocol of a pilot cluster randomised trial. Pilot Feasibility Stud; 6:3 doi:10.1186/s40814-019-0547-x
  • Manthey J, Lindemann C, Kraus L, Reimer J, Verthein U, Schulte B, Rehm J (2020) The potential effects of an extended alcohol withdrawal treatment programme on morbidity and mortality among inpatients in the German city of Bremen: a simulation study. Subst Abuse Treat Prev Policy; 2:15. doi: 10.1186/s13011-019-0249-7
  • Manthey J, Lindemann C, Verthein U, Frischknecht U, Kraus L, Reimer J, Grün A, Kiefer F, Schulte B, Rehm J (2020) Versorgung von Personen mit riskantem Alkoholkonsum und schwerer Alkoholkonsumstörung in Bremen: bedarfsgerecht und leitlinienkonform? Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz; 63:122-130. doi: 10.1007/s00103-019-03072-z
  • Shield K, Manthey J, Rylett M, Probst C, Wettlaufer A, Parry C, Rehm J (2020). National, regional, and global burdens of disease from 2000 to 2016 attributable to alcohol use: a comparative risk assessment study. The Lancet Public Health. 5. doi: 10.1016/S2468-2667(19)30231-2.